VEGF receptor inhibitors block the ability of metronomically dosed cyclophosphamide to activate innate immunity-induced tumor regression

Lignende værker

• Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts
  af: Doloff, Joshua C, et al.
  Udgivet: (2015)
• Intermittent Metronomic Drug Schedule Is Essential for Activating Antitumor Innate Immunity and Tumor Xenograft Regression
  af: Chen, Chong-Sheng, et al.
  Udgivet: (2014)
• Anti-tumor innate immunity activated by intermittent metronomic cyclophosphamide treatment of 9L brain tumor xenografts is preserved by anti-angiogenic drugs that spare VEGF receptor 2
  af: Doloff, Joshua C, et al.
  Udgivet: (2014)
• Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model
  af: Wu, Junjie, et al.
  Udgivet: (2014)
• Modulation of the Antitumor Activity of Metronomic Cyclophosphamide by the Angiogenesis Inhibitor Axitinib
  af: Ma, Jie, et al.
  Udgivet: (2008)